c-Myc inhibitors (Clinical Data)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namec-Myc inhibitors (Clinical Data)
Drug Alias Namec-Myc inhibitors (Avalon)AV-myc-1AV-myc-2
ClassificationSmall molecules
Mechanisms of ActionMyc proto-oncogene protein inhibitors
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvalon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClinical Data IncAvalon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A